Hims & Hers Health (HIMS) Inventory Average (2021 - 2026)
Hims & Hers Health (HIMS) posted Inventory Average of $79.6 million for Q1 2026, down 14.46% sequentially from $93.1 million in Q4 2025, and up 13.29% YoY from $70.3 million in Q1 2025.
Hims & Hers Health (HIMS) Inventory Average (2021 - 2026) Analysis & Trends
Hims & Hers Health has reported Inventory Average for 6 years, with the latest figure at $79.6 million in Q1 2026.
- Quarterly Inventory Average rose 13.29% year-over-year to $79.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $79.6 million (up 13.29% YoY) and the FY2025 annual result came in at $72.3 million, up 66.36% from the prior year.
- Inventory Average slipped to $79.6 million in Q1 2026 per HIMS's latest filing, from $93.1 million in the prior quarter.
- Over five years, Inventory Average peaked at $123.9 million in Q3 2025 and troughed at $12.9 million in Q1 2022.
- A 5-year average of $46.9 million and a median of $26.1 million in 2024 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2022 and 2023: Inventory Average jumped 218.63% in 2022, then advanced 1.25% in 2023.
- Over 5 years, Inventory Average stood at $22.0 million in 2022, then advanced by 1.25% to $22.2 million in 2023, then jumped by 155.39% to $56.8 million in 2024, then jumped by 63.93% to $93.1 million in 2025, then retreated by 14.46% to $79.6 million in 2026.
- According to Business Quant data, Inventory Average over the past three periods registered $79.6 million, $93.1 million, and $123.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 1.41 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.20 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.56 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 8.99 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 186.05 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 84.35 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.74 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 824.00 Mn |
| 10 | Hims & Hers Health | 7.42 Bn | 6.57 Bn | 480.80 Mn | 83.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 83.43 Mn |
| Mar 31, 2026 | 79.60 Mn |
| Dec 31, 2025 | 93.06 Mn |
| Sep 30, 2025 | 123.89 Mn |
| Jun 30, 2025 | 108.95 Mn |
| Mar 31, 2025 | 70.26 Mn |
| Dec 31, 2024 | 56.77 Mn |
| Sep 30, 2024 | 44.85 Mn |
| Jun 30, 2024 | 35.21 Mn |
| Mar 31, 2024 | 26.15 Mn |
| Dec 31, 2023 | 22.23 Mn |
| Sep 30, 2023 | 21.70 Mn |
| Jun 30, 2023 | 21.06 Mn |
| Mar 31, 2023 | 21.13 Mn |
| Dec 31, 2022 | 21.95 Mn |
| Sep 30, 2022 | 21.01 Mn |
| Jun 30, 2022 | 15.91 Mn |
| Mar 31, 2022 | 12.85 Mn |
| Dec 31, 2021 | 12.21 Mn |
| Sep 30, 2021 | 8.72 Mn |